OxyContin maker Purdue Pharma made plans to launch a foundation to fund opioid-addiction treatment and research, then scrapped the project amid hundreds of lawsuits and a possible bankruptcy filing
OxyContin maker Purdue Pharma LP nixed plans earlier this year to launch a foundation to fund opioid-addiction treatment and research as the company rethought its strategy amid hundreds of lawsuits and a possible bankruptcy filing.
Purdue staff pitched the foundation concept several years ago, and the drugmaker’s owners and executives spent several months developing the latest version, according to people familiar with the matter and internal company emails viewed by The Wall Street Journal.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
WSJ News Exclusive | Charles Schwab to Cut 600 Employees, or About 3% of StaffCharles Schwab's move to trim staff comes as firms across Wall Street and beyond grapple with a shift in Federal Reserve policy
Consulte Mais informação »
WSJ News Exclusive | Groupon Said to Be Pursuing Acquisition as Business Faces Pressure From InvestorsDaily-deals company Groupon is pursuing an acquisition amid discontent among shareholders about the firm’s financial performance and stock price, people familiar with the matter say. The target could be Yelp, the San Francisco-based online-review company, according to two other people familiar with the situation.
Consulte Mais informação »
WSJ News Exclusive | Nissan Management Withholds Full Ghosn Report From BoardNissan Motor’s management has yet to give its board the complete 170-page report detailing alleged wrongdoing by former Chairman Carlos Ghosn, drawing complaints from some directors.
Consulte Mais informação »
WSJ News Exclusive | Big U.S. Banks Crowd Into Aramco IPOGlobal investment bankers launched the underwriting process for the initial public offering of Saudi oil giant Aramco, a sign financiers who shunned the kingdom after the murder of journalist Jamal Khashoggi are turning the page.
Consulte Mais informação »